SAN FRANCISCO, CA (MARKET WIRE) AmStem Corporation (OTCBB: AMST), a world leader in stem cell research using stem cells collected from the umbilical cord immediately after birth, has found an innovative use for those cord blood stem cells that are unable to be used for transplant or regenerative medicine purposes.

